TY  - BOOK
AU  - Sharma,Kavita
AU  - Manchikanti,Padmavati
ED  - SpringerLink (Online service)
TI  - Artificial Intelligence in Drug Development: Patenting and Regulatory Aspects 
T2  - Frontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications,
SN  - 9789819729548
AV  - K4240-4343 
PY  - 2024///
CY  - Singapore
PB  - Springer Nature Singapore, Imprint: Springer
KW  - Information technology
KW  - Law and legislation
KW  - Mass media
KW  - Health services administration
KW  - Artificial intelligence
KW  - IT Law, Media Law, Intellectual Property
KW  - Health Care Management
KW  - Artificial Intelligence
N1  - Artificial Intelligence in Drug Development - Nature and Scope -- Analysis of AI Related Patents in the Healthcare -- Regulation of AI in Drug Development -- Policy and Regulation for AI for Indian Drug and Healthcare Industry -- Way forward for Patenting and Regulation in relation to AI
N2  - This book discusses how Artificial Intelligence developments have revolutionized the area of medicine and how companies use them to develop applications. While the book covers the growth of AI in medicine and the early developments in AI based medical tools, it provides an in-depth analysis of the current developments in relation to the area of medical diagnostics. The book focuses on how enterprises and institutes have developed their intellectual property portfolio, particularly patents, in this area. Cross-country patenting analysis helps in understanding key areas of growth in certain markets and also company strategies and arrangements. The introduction of AI based products in market is subject to regulation. The developments in policy and regulation influence the development and deployment of such products into the market. This book brings focus to the development of policy and regulation and how regulatory developments impact the introduction of AI-based healthcare products from a cross-country perspective. Further, how regulatory developments lead to the evolution of standards, build reliability and safety in this area are also examined. The unique aspect of this book is the comprehensive coverage of the dual aspects of the nature and scope of AI-based innovations in health care and the related drug regulatory aspects which are imperative for the understanding for students, researchers, and those who work in this area
UR  - https://doi.org/10.1007/978-981-97-2954-8
ER  -